SG11202010208YA - The kit for screening colorectal cancer and advanced adenoma and its application - Google Patents
The kit for screening colorectal cancer and advanced adenoma and its applicationInfo
- Publication number
- SG11202010208YA SG11202010208YA SG11202010208YA SG11202010208YA SG11202010208YA SG 11202010208Y A SG11202010208Y A SG 11202010208YA SG 11202010208Y A SG11202010208Y A SG 11202010208YA SG 11202010208Y A SG11202010208Y A SG 11202010208YA SG 11202010208Y A SG11202010208Y A SG 11202010208YA
- Authority
- SG
- Singapore
- Prior art keywords
- kit
- application
- colorectal cancer
- advanced adenoma
- screening colorectal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/721—Haemoglobin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2561/00—Nucleic acid detection characterised by assay method
- C12Q2561/113—Real time assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/166—Oligonucleotides used as internal standards, controls or normalisation probes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810502359.7A CN108660209B (en) | 2018-05-23 | 2018-05-23 | Product for early detection of colorectal cancer prepared based on BMP3 gene methylation |
CN201810502387.9A CN108676878B (en) | 2018-05-23 | 2018-05-23 | Application of product for detecting NDRG4 gene methylation site in preparation of product for early detection of colorectal cancer |
PCT/US2019/033831 WO2019226942A1 (en) | 2018-05-23 | 2019-05-23 | The kit for screening colorectal cancer and advanced adenoma and its application |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202010208YA true SG11202010208YA (en) | 2020-11-27 |
Family
ID=68617194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202010208YA SG11202010208YA (en) | 2018-05-23 | 2019-05-23 | The kit for screening colorectal cancer and advanced adenoma and its application |
Country Status (10)
Country | Link |
---|---|
US (1) | US20210207221A1 (en) |
EP (1) | EP3797112A4 (en) |
JP (1) | JP2021526370A (en) |
KR (1) | KR20210035094A (en) |
CN (1) | CN112752763A (en) |
AU (1) | AU2019275073A1 (en) |
BR (1) | BR112020023274A2 (en) |
CA (1) | CA3098028A1 (en) |
SG (1) | SG11202010208YA (en) |
WO (1) | WO2019226942A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113278693A (en) * | 2020-07-29 | 2021-08-20 | 上海吉凯医学检验所有限公司 | DNA methylation marker for early colorectal cancer and adenoma, method for detecting same and application thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
EA007028B1 (en) * | 2000-09-01 | 2006-06-30 | Эпигеномикс Аг | Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
DE10112515B4 (en) * | 2001-03-09 | 2004-02-12 | Epigenomics Ag | Method for the detection of cytosine methylation patterns with high sensitivity |
CA2835345C (en) * | 2011-05-12 | 2021-03-09 | Exact Sciences Corporation | Isolation of nucleic acids |
EP2828405B1 (en) * | 2012-03-20 | 2017-06-28 | Exact Sciences Corporation | Marker panel for detecting cancer |
US10301680B2 (en) * | 2014-03-31 | 2019-05-28 | Mayo Foundation For Medical Education And Research | Detecting colorectal neoplasm |
CN113981057A (en) * | 2014-12-12 | 2022-01-28 | 精密科学公司 | Compositions and methods for performing methylation detection assays |
US10011878B2 (en) * | 2014-12-12 | 2018-07-03 | Exact Sciences Development Company | Compositions and methods for performing methylation detection assays |
CN104975110A (en) * | 2015-06-02 | 2015-10-14 | 浙江诺辉生物技术有限公司 | Primer and probe for detecting methylation levels of BMP3 and NDRG4 in biological sample |
AU2016343937B2 (en) * | 2015-10-30 | 2023-01-19 | Exact Sciences Corporation | Multiplex amplification detection assay and isolation and detection of DNA from plasma |
WO2018087129A1 (en) * | 2016-11-08 | 2018-05-17 | Region Nordjylland, Aalborg University Hospital | Colorectal cancer methylation markers |
CN106399570A (en) * | 2016-11-30 | 2017-02-15 | 杭州诺辉健康科技有限公司 | Kit for early stage colorectal cancer auxiliary diagnosis and use method and detection system thereof |
-
2019
- 2019-05-23 CN CN201980033966.6A patent/CN112752763A/en active Pending
- 2019-05-23 KR KR1020207037127A patent/KR20210035094A/en unknown
- 2019-05-23 JP JP2020564893A patent/JP2021526370A/en active Pending
- 2019-05-23 WO PCT/US2019/033831 patent/WO2019226942A1/en unknown
- 2019-05-23 EP EP19806858.7A patent/EP3797112A4/en active Pending
- 2019-05-23 AU AU2019275073A patent/AU2019275073A1/en active Pending
- 2019-05-23 US US17/057,227 patent/US20210207221A1/en active Pending
- 2019-05-23 SG SG11202010208YA patent/SG11202010208YA/en unknown
- 2019-05-23 BR BR112020023274-2A patent/BR112020023274A2/en unknown
- 2019-05-23 CA CA3098028A patent/CA3098028A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3797112A4 (en) | 2022-03-23 |
US20210207221A1 (en) | 2021-07-08 |
AU2019275073A8 (en) | 2020-12-10 |
JP2021526370A (en) | 2021-10-07 |
WO2019226942A1 (en) | 2019-11-28 |
KR20210035094A (en) | 2021-03-31 |
BR112020023274A2 (en) | 2021-02-23 |
CN112752763A (en) | 2021-05-04 |
AU2019275073A1 (en) | 2020-11-26 |
EP3797112A1 (en) | 2021-03-31 |
CA3098028A1 (en) | 2019-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201808476D0 (en) | Biomarkers for colorectal cancer | |
EP3576781A4 (en) | Neoantigens and uses thereof for treating cancer | |
IL275805A (en) | Methods for treating colorectal and metastatic colorectal cancers | |
EP3303610A4 (en) | Compositions and methods for screening solid tumors | |
EP3801563A4 (en) | Materials and methods for treating cancer | |
HK1252142A1 (en) | Fecal bacterial markers for colorectal cancer | |
EP3647788A4 (en) | Biomarker for detecting colorectal cancer | |
EP3271483A4 (en) | Methods and materials for assessing and treating cancer | |
GB201703816D0 (en) | Protein biomarker panels for detecting colorectal cancer and advanced adenoma | |
IL264359A (en) | Combination test for colorectal cancer | |
IL283165A (en) | Adenoviruses and methods for using adenoviruses | |
EP3873205A4 (en) | Materials and methods for treating cancer | |
EP3870104A4 (en) | Methods and materials for treating cancer | |
GB201821206D0 (en) | Analytical methods | |
GB201812561D0 (en) | Biomarkers and uses thereof | |
GB201806042D0 (en) | Biomarkers and uses thereof | |
EP3568145A4 (en) | Materials and methods for treating cancer | |
SG11202010208YA (en) | The kit for screening colorectal cancer and advanced adenoma and its application | |
EP3773625A4 (en) | Methods and materials for treating cancer | |
GB201814487D0 (en) | Cancer | |
GB201801102D0 (en) | New compounds and uses | |
EP3675893A4 (en) | Methods for treating and diagnosing metastatic liver cancer | |
EP3873540A4 (en) | Methods and materials for treating cancer | |
EP3829616A4 (en) | Methods and materials for treating cancer | |
GB201913957D0 (en) | Cancer |